spacer
home > pmps > summer 2017 > intriguing injections
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Intriguing Injections

PMPS: What are pre-filled syringes (PFSs) and what are they most commonly used for?

Kevin O’Brien: PFSs, by design, are self-administering drug delivery systems. This home-friendly device offers significant benefits to patients, healthcare professionals and manufacturers compared to traditional ‘vial and syringe’ methods. The majority of medications delivered by PFSs are used for chronic diseases, such as diabetes, rheumatoid arthritis and multiple sclerosis. The healthcare industry is increasingly seeing price pressures that generate a growing need for innovative ways to reduce expenses. Thus, these systems are a cost-saving option.

What advantages do patients receive from using a PFS as opposed to other drug delivery systems?

Ultimately, they receive convenience, bettering their quality of life. PFSs allow medication to be safely administered at home, eliminating travel time and doctor office visits. PFSs are becoming of greater interest among many pharmaceutical manufacturers due to their ease-ofuse, which means that these systems can be offered at a premium price. Overall, a PFS makes self-injection easier, and dosing is much more accurate than the traditional vial and syringe, which, in turn, improves patient compliance and outcomes.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kevin O’Brien is Vice President at Siegfried. Before joining the company, he held General Manager positions at Horizon Medical, Surgical Technologies and Pharmacia. Kevin has worked in the medical device and pharma industry since 1986. His background includes both Operations Management and Business Development.
spacer
Kevin O’Brien
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mironid Announces Closing of £4.3 million ($6.2 million) Series A Financing

Cell signalling in drug development company today announced the closure of its Series A funding round
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

Cell Therapy Manufacturing & Gene Therapy Congress

6-7 December 2017, RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 6 - 7 December 2017 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to transforming innovative research to prosperous cell & gene manufacturing.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement